Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20200121002Phase 2Completed
Phase 2, randomised trial of nimodipine in cerebral vasospasm and subarachnoid hemorrhage (SAH) (2 arms), sponsored by None. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20200121002.